25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BBLG (Bone Biologics Corp) Stock Analysis
Buy, Hold or Sell?

Let's analyze Bone Biologics Corp together

I guess you are interested in Bone Biologics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Bone Biologics Corp’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Bone Biologics Corp’s Price Targets

I'm going to help you getting a better view of Bone Biologics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bone Biologics Corp

I send you an email if I find something interesting about Bone Biologics Corp.

1. Quick Overview

1.1. Quick analysis of Bone Biologics Corp (30 sec.)










1.2. What can you expect buying and holding a share of Bone Biologics Corp? (30 sec.)

How much money do you get?

How much money do you get?
$2.88
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$3.67
Expected worth in 1 year
$5.73
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$4.93
Return On Investment
224.1%

For what price can you sell your share?

Current Price per Share
$2.20
Expected price per share
$1.95 - $3.155
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bone Biologics Corp (5 min.)




Live pricePrice per Share (EOD)
$2.20
Intrinsic Value Per Share
$-25.58 - $-13.41
Total Value Per Share
$-21.91 - $-9.74

2.2. Growth of Bone Biologics Corp (5 min.)




Is Bone Biologics Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$6.5m$3.3m$874.9k20.9%

How much money is Bone Biologics Corp making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$1.2m$224.8k21.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Bone Biologics Corp (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#222 / 293

Most Revenue
#289 / 293

Most Profit
#153 / 293

Most Efficient
#116 / 293
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bone Biologics Corp?

Welcome investor! Bone Biologics Corp's management wants to use your money to grow the business. In return you get a share of Bone Biologics Corp.

First you should know what it really means to hold a share of Bone Biologics Corp. And how you can make/lose money.

Speculation

The Price per Share of Bone Biologics Corp is $2.2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bone Biologics Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bone Biologics Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.67. Based on the TTM, the Book Value Change Per Share is $0.51 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.72 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bone Biologics Corp.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.41-18.7%-0.44-20.1%-0.71-32.4%-0.69-31.3%-0.49-22.3%-0.89-40.3%
Usd Book Value Change Per Share2.76125.4%0.5123.3%-0.39-17.6%0.052.1%0.209.3%0.104.7%
Usd Dividend Per Share0.000.0%0.7232.7%0.000.0%0.2410.9%0.146.5%0.073.3%
Usd Total Gains Per Share2.76125.4%1.2356.0%-0.39-17.6%0.2913.0%0.3515.8%0.188.0%
Usd Price Per Share4.03-1.98-2.15-1.62-1.36-0.68-
Price to Earnings Ratio-2.44--1.14--0.82--0.72--1.04--0.52-
Price-to-Total Gains Ratio1.46-1.37--1.93--0.24--1.16--0.76-
Price to Book Ratio1.10-0.94-1.23-0.82-0.60-0.30-
Price-to-Total Gains Ratio1.46-1.37--1.93--0.24--1.16--0.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.2
Number of shares454
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.720.14
Usd Book Value Change Per Share0.510.20
Usd Total Gains Per Share1.230.35
Gains per Quarter (454 shares)559.64158.21
Gains per Year (454 shares)2,238.56632.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
113069322229261372623
22612186544685227431256
339182797670778411151889
4522537308946104514872522
56531466211185130618583155
67837559513424156722303788
79143652715663182926014421
810449745917902209029735054
911755839220141235133455687
1013061932422380261237166320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.049.00.02.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%6.014.00.030.0%11.029.00.027.5%15.035.00.030.0%
Dividend per Share2.00.02.050.0%2.00.010.016.7%2.00.018.010.0%2.00.038.05.0%2.00.048.04.0%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%7.013.00.035.0%12.028.00.030.0%16.034.00.032.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bone Biologics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.7600.513+437%-0.388+114%0.047+5799%0.205+1249%0.104+2544%
Book Value Per Share--3.6741.970+86%1.850+99%2.147+71%0.529+594%-1.748+148%
Current Ratio--17.24113.731+26%10.812+59%9.471+82%18.578-7%11.025+56%
Debt To Asset Ratio--0.0580.076-23%0.148-61%0.183-68%736.491-100%652.301-100%
Debt To Equity Ratio--0.0620.082-25%0.185-67%0.289-79%0.175-65%0.088-30%
Dividend Per Share---0.719-100%-0%0.240-100%0.144-100%0.072-100%
Enterprise Value--13469223.8007838031.900+72%6494604.450+107%6594119.762+104%7378130.276+83%1799876.556+648%
Eps---0.412-0.443+7%-0.713+73%-0.688+67%-0.491+19%-0.888+115%
Ev To Ebitda Ratio---4.5015.839-177%3.004-250%2.804-261%0.355-1370%0.954-572%
Free Cash Flow Per Share---0.256-0.331+29%-0.943+269%-0.765+199%-0.527+106%-0.537+110%
Free Cash Flow To Equity Per Share--2.1690.648+235%-0.034+102%0.690+214%0.566+283%0.302+617%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.035-3%1.017-2%
Intrinsic Value_10Y_max---13.415----------
Intrinsic Value_10Y_min---25.581----------
Intrinsic Value_1Y_max---2.033----------
Intrinsic Value_1Y_min---2.994----------
Intrinsic Value_3Y_max---5.583----------
Intrinsic Value_3Y_min---8.677----------
Intrinsic Value_5Y_max---8.501----------
Intrinsic Value_5Y_min---13.965----------
Market Cap3949572.000-83%7234897.8004095490.400+77%3850832.700+88%3089959.512+134%2545150.807+184%1273416.394+468%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio0.599-83%1.0970.944+16%1.230-11%0.817+34%0.602+82%0.301+264%
Pe Ratio-1.333+45%-2.443-1.135-54%-0.819-66%-0.724-70%-1.036-58%-0.518-79%
Price Per Share2.200-83%4.0301.975+104%2.145+88%1.619+149%1.356+197%0.679+494%
Price To Free Cash Flow Ratio-2.152+45%-3.942-1.703-57%-0.619-84%-0.899-77%-1.122-72%-0.561-86%
Price To Total Gains Ratio0.797-83%1.4601.366+7%-1.926+232%-0.238+116%-1.163+180%-0.759+152%
Quick Ratio--16.35012.283+33%9.400+74%8.452+93%17.567-7%9.980+64%
Return On Assets---0.106-0.263+149%-0.318+201%-0.269+155%-23.729+22338%-22.007+20709%
Return On Equity---0.112-0.287+155%-0.386+244%-0.372+232%-0.235+109%-0.117+4%
Total Gains Per Share--2.7601.233+124%-0.388+114%0.287+863%0.348+692%0.176+1465%
Usd Book Value--6596074.0004195762.250+57%3320843.750+99%4073368.750+62%-185539.550+103%-4414293.550+167%
Usd Book Value Change Per Share--2.7600.513+437%-0.388+114%0.047+5799%0.205+1249%0.104+2544%
Usd Book Value Per Share--3.6741.970+86%1.850+99%2.147+71%0.529+594%-1.748+148%
Usd Dividend Per Share---0.719-100%-0%0.240-100%0.144-100%0.072-100%
Usd Enterprise Value--13469223.8007838031.900+72%6494604.450+107%6594119.762+104%7378130.276+83%1799876.556+648%
Usd Eps---0.412-0.443+7%-0.713+73%-0.688+67%-0.491+19%-0.888+115%
Usd Free Cash Flow---458879.000-827664.500+80%-1693128.500+269%-1450992.333+216%-1002962.900+119%-1009141.350+120%
Usd Free Cash Flow Per Share---0.256-0.331+29%-0.943+269%-0.765+199%-0.527+106%-0.537+110%
Usd Free Cash Flow To Equity Per Share--2.1690.648+235%-0.034+102%0.690+214%0.566+283%0.302+617%
Usd Market Cap3949572.000-83%7234897.8004095490.400+77%3850832.700+88%3089959.512+134%2545150.807+184%1273416.394+468%
Usd Price Per Share2.200-83%4.0301.975+104%2.145+88%1.619+149%1.356+197%0.679+494%
Usd Profit---740519.000-1055129.750+42%-1280000.000+73%-1262088.250+70%-938090.950+27%-1671682.950+126%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share--2.7601.233+124%-0.388+114%0.287+863%0.348+692%0.176+1465%
 EOD+2 -6MRQTTM+29 -5YOY+30 -23Y+29 -55Y+27 -810Y+29 -6

3.3 Fundamental Score

Let's check the fundamental score of Bone Biologics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.333
Price to Book Ratio (EOD)Between0-10.599
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than116.350
Current Ratio (MRQ)Greater than117.241
Debt to Asset Ratio (MRQ)Less than10.058
Debt to Equity Ratio (MRQ)Less than10.062
Return on Equity (MRQ)Greater than0.15-0.112
Return on Assets (MRQ)Greater than0.05-0.106
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Bone Biologics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.450
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Bone Biologics Corp

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Fundamental data was last updated by Penke on 2025-10-21 22:29:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Bone Biologics Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Bone Biologics Corp to theΒ Medical Devices industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bone Biologics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.8%+4.8%
TTM--6.3%+6.3%
YOY--12.2%+12.2%
3Y--12.3%+12.3%
5Y--11.1%+11.1%
10Y--9.6%+9.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Bone Biologics Corp is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Bone Biologics Corp to theΒ Medical Devices industry mean.
  • -10.6% Return on Assets means thatΒ Bone Biologics Corp generatedΒ $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bone Biologics Corp:

  • The MRQ is -10.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.6%TTM-26.3%+15.7%
TTM-26.3%YOY-31.8%+5.5%
TTM-26.3%5Y-2,372.9%+2,346.6%
5Y-2,372.9%10Y-2,200.7%-172.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.6%-1.4%-9.2%
TTM-26.3%-1.5%-24.8%
YOY-31.8%-2.6%-29.2%
3Y-26.9%-2.4%-24.5%
5Y-2,372.9%-2.2%-2,370.7%
10Y-2,200.7%-1.6%-2,199.1%
4.3.1.3. Return on Equity

Shows how efficient Bone Biologics Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Bone Biologics Corp to theΒ Medical Devices industry mean.
  • -11.2% Return on Equity means Bone Biologics Corp generated $-0.11Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bone Biologics Corp:

  • The MRQ is -11.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.2%TTM-28.7%+17.4%
TTM-28.7%YOY-38.6%+9.9%
TTM-28.7%5Y-23.5%-5.2%
5Y-23.5%10Y-11.7%-11.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.2%-1.2%-10.0%
TTM-28.7%-1.4%-27.3%
YOY-38.6%-2.6%-36.0%
3Y-37.2%-3.4%-33.8%
5Y-23.5%-3.9%-19.6%
10Y-11.7%-4.0%-7.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bone Biologics Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Bone Biologics Corp is operatingΒ .

  • Measures how much profit Bone Biologics Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Bone Biologics Corp to theΒ Medical Devices industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bone Biologics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.3%+11.3%
TTM--12.8%+12.8%
YOY--14.8%+14.8%
3Y--10.5%+10.5%
5Y--9.0%+9.0%
10Y--8.6%+8.6%
4.3.2.2. Operating Ratio

Measures how efficient Bone Biologics Corp is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bone Biologics Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.297-1.297
TTM-1.316-1.316
YOY-1.221-1.221
3Y-1.285-1.285
5Y-1.287-1.287
10Y-1.269-1.269
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bone Biologics Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bone Biologics Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 17.24Β means the company has $17.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bone Biologics Corp:

  • The MRQ is 17.241. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.731. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ17.241TTM13.731+3.510
TTM13.731YOY10.812+2.919
TTM13.7315Y18.578-4.847
5Y18.57810Y11.025+7.553
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ17.2412.414+14.827
TTM13.7312.593+11.138
YOY10.8122.691+8.121
3Y9.4712.850+6.621
5Y18.5783.548+15.030
10Y11.0253.426+7.599
4.4.3.2. Quick Ratio

Measures if Bone Biologics Corp is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Bone Biologics Corp to theΒ Medical Devices industry mean.
  • A Quick Ratio of 16.35Β means the company can pay off $16.35 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bone Biologics Corp:

  • The MRQ is 16.350. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.283. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ16.350TTM12.283+4.067
TTM12.283YOY9.400+2.884
TTM12.2835Y17.567-5.284
5Y17.56710Y9.980+7.587
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ16.3501.334+15.016
TTM12.2831.494+10.789
YOY9.4001.752+7.648
3Y8.4521.910+6.542
5Y17.5672.290+15.277
10Y9.9802.521+7.459
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bone Biologics Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Bone Biologics CorpΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Bone Biologics Corp to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.06Β means that Bone Biologics Corp assets areΒ financed with 5.8% credit (debt) and the remaining percentage (100% - 5.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Bone Biologics Corp:

  • The MRQ is 0.058. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.076. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.058TTM0.076-0.018
TTM0.076YOY0.148-0.072
TTM0.0765Y736.491-736.416
5Y736.49110Y652.301+84.190
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0580.413-0.355
TTM0.0760.420-0.344
YOY0.1480.393-0.245
3Y0.1830.396-0.213
5Y736.4910.407+736.084
10Y652.3010.454+651.847
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Bone Biologics Corp is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Bone Biologics Corp to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 6.2% means that company has $0.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bone Biologics Corp:

  • The MRQ is 0.062. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.082. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.082-0.021
TTM0.082YOY0.185-0.103
TTM0.0825Y0.175-0.093
5Y0.17510Y0.088+0.088
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.646-0.584
TTM0.0820.673-0.591
YOY0.1850.584-0.399
3Y0.2890.646-0.357
5Y0.1750.632-0.457
10Y0.0880.753-0.665
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Bone Biologics Corp generates.

  • Above 15 is considered overpriced butΒ always compareΒ Bone Biologics Corp to theΒ Medical Devices industry mean.
  • A PE ratio of -2.44 means the investor is paying $-2.44Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bone Biologics Corp:

  • The EOD is -1.333. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.443. Based on the earnings, the company is expensive. -2
  • The TTM is -1.135. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.333MRQ-2.443+1.109
MRQ-2.443TTM-1.135-1.307
TTM-1.135YOY-0.819-0.316
TTM-1.1355Y-1.036-0.099
5Y-1.03610Y-0.518-0.518
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.333-0.912-0.421
MRQ-2.443-1.008-1.435
TTM-1.135-1.228+0.093
YOY-0.819-2.571+1.752
3Y-0.724-1.074+0.350
5Y-1.036-1.290+0.254
10Y-0.518-1.055+0.537
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bone Biologics Corp:

  • The EOD is -2.152. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.942. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.703. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.152MRQ-3.942+1.790
MRQ-3.942TTM-1.703-2.238
TTM-1.703YOY-0.619-1.085
TTM-1.7035Y-1.122-0.581
5Y-1.12210Y-0.561-0.561
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.152-1.565-0.587
MRQ-3.942-1.837-2.105
TTM-1.703-1.633-0.070
YOY-0.619-3.251+2.632
3Y-0.899-2.200+1.301
5Y-1.122-4.000+2.878
10Y-0.561-4.000+3.439
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Bone Biologics Corp is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 1.10 means the investor is paying $1.10Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bone Biologics Corp:

  • The EOD is 0.599. Based on the equity, the company is cheap. +2
  • The MRQ is 1.097. Based on the equity, the company is underpriced. +1
  • The TTM is 0.944. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.599MRQ1.097-0.498
MRQ1.097TTM0.944+0.153
TTM0.944YOY1.230-0.286
TTM0.9445Y0.602+0.342
5Y0.60210Y0.301+0.301
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.5992.354-1.755
MRQ1.0972.126-1.029
TTM0.9442.312-1.368
YOY1.2302.514-1.284
3Y0.8172.716-1.899
5Y0.6023.843-3.241
10Y0.3014.325-4.024
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bone Biologics Corp.

4.8.1. Institutions holding Bone Biologics Corp

Institutions are holding 0.025% of the shares of Bone Biologics Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Tower Research Capital LLC0.01110200-104-34.2105
2025-06-30CLEAR STREET LLC.0.007701381380
2025-06-30UBS Group AG0.006301131130
2025-06-30Bank of America Corp0.000204133.3333
2025-06-30Geode Capital Management, LLC000-4034-100
2025-06-30SBI Securities Co Ltd00000
2025-03-31Citigroup Inc000-4948-100
2025-03-31HRT FINANCIAL LLC000-14658-100
Total 0.02530455-23492-5,163.1%

4.9.2. Funds holding Bone Biologics Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Fidelity Extended Market Index0.15340275400
2025-07-31Spartan Extended Market Index Pool F0.08650.0001155300
2025-07-31Fidelity Total Market Index0.0365065600
2025-07-31Fidelity Series Total Market Index0.0348062500
Total 0.31120.0001558800.0%

5.3. Insider Transactions

Insiders are holding 8.309% of the shares of Bone Biologics Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-13Deina H WalshBUY16630.72
2023-09-11Jeff FrelickBUY19733.12
2023-09-06Deina H WalshBUY14534.08
2023-08-31Jeff FrelickBUY15831.68
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets7,002
Total Liabilities406
Total Stockholder Equity6,596
 As reported
Total Liabilities 406
Total Stockholder Equity+ 6,596
Total Assets = 7,002

Assets

Total Assets7,002
Total Current Assets7,002
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 6,640
Other Current Assets 362
Total Current Assets  (as reported)7,002
Total Current Assets  (calculated)7,002
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities406
Long-term Liabilities0
Total Stockholder Equity6,596
Total Current Liabilities
Accounts payable 404
Other Current Liabilities 406
Total Current Liabilities  (as reported)406
Total Current Liabilities  (calculated)810
+/- 404
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -86,779
Other Stockholders Equity 93,373
Total Stockholder Equity (as reported)6,596
Total Stockholder Equity (calculated)6,596
+/-0
Other
Capital Stock2
Cash and Short Term Investments 6,640
Common Stock Shares Outstanding 558
Liabilities and Stockholders Equity 7,002
Net Debt -6,640
Net Invested Capital 6,596
Net Working Capital 6,596



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-06-302013-03-312012-12-312012-06-302012-03-312011-12-312011-06-302011-03-312010-12-312010-06-302010-03-312009-12-312009-06-302009-03-312008-12-312008-06-302008-03-31
> Total Assets 
-27
-22
1
0
0
-40
0
0
0
0
0
0
0
0
0
0
0
87
0
126
420
3,821
3,216
4,413
3,302
2,080
4,622
2,635
1,072
973
1,968
1,140
1,941
796
470
378
2,350
1,041
814
266
249
31
7
1
2
0
71
4
52
6,675
6,094
5,659
5,201
8,495
6,784
7,623
4,976
3,738
3,840
3,193
4,066
3,861
3,162
7,002
7,0023,1623,8614,0663,1933,8403,7384,9767,6236,7848,4955,2015,6596,0946,675524710217312492668141,0412,3503784707961,9411,1401,9689731,0722,6354,6222,0803,3024,4133,2163,82142012608700000000000-40001-22-27
   > Total Current Assets 
-27
-22
0
0
0
-40
0
0
0
0
0
0
0
0
0
2
0
87
2
126
420
3,810
3,204
4,402
3,291
2,074
4,622
2,634
1,072
701
1,968
1,140
1,940
796
470
378
2,350
1,041
814
266
249
31
7
1
2
0
71
4
52
6,675
6,094
5,659
5,201
8,495
6,784
7,623
4,976
3,738
3,840
3,193
4,066
3,861
3,162
7,002
7,0023,1623,8614,0663,1933,8403,7384,9767,6236,7848,4955,2015,6596,0946,675524710217312492668141,0412,3503784707961,9401,1401,9687011,0722,6344,6222,0743,2914,4023,2043,81042012628702000000000-40000-22-27
       Cash And Cash Equivalents 
-27
-22
0
0
0
-40
0
0
0
0
0
0
0
0
0
-2
0
2
-2
0
15
2,661
2,169
3,167
2,126
1,115
4,221
2,194
688
620
1,612
783
1,622
690
371
305
2,294
955
726
176
202
24
2
0
2
0
71
4
3
6,675
5,815
5,455
5,059
7,538
6,188
7,008
4,453
3,027
3,228
2,332
3,566
3,325
2,747
6,640
6,6402,7473,3253,5662,3323,2283,0274,4537,0086,1887,5385,0595,4555,8156,67534710202242021767269552,2943053716901,6227831,6126206882,1944,2211,1152,1263,1672,1692,661150-220-2000000000-40000-22-27
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000003005000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
340
301
301
301
272
272
272
272
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
580
0
0
0
329
329
0
0
0
0
0
00000329329000580000000000000000000002722722722723013013013400000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86
0
126
405
1,148
1,035
1,236
1,165
426
400
440
384
81
355
357
318
105
99
73
56
85
88
90
48
7
0
0
0
0
1
0
49
0
279
204
142
957
595
615
524
711
612
861
499
536
416
362
362416536499861612711524615595957142204279049010000748908885567399105318357355813844404004261,1651,2361,0351,14840512608600000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2
0
0
-2
0
0
12
12
11
10
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000061011121200-200-2000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
11
10
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000610111212000000000000000000000
       Other Assets 
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
52
0
279
204
142
957
595
615
524
0
0
0
0
0
0
0
0000000524615595957142204279052010000000000000000000000000000000000000000000100
> Total Liabilities 
0
0
17
0
0
0
0
0
0
0
0
0
0
0
5
0
39
5,695
44
6,345
4,772
7,520
7,800
5,311
5,500
7,761
7,634
7,950
8,123
9,607
10,238
11,390
12,845
9,191
9,005
9,834
9,525
9,639
10,786
11,122
11,631
11,898
12,471
12,846
13,241
13,692
14,195
14,620
15,178
100
55
71
799
2,548
4,011
1,930
1,183
831
165
285
273
378
251
406
4062513782732851658311,1831,9304,0112,548799715510015,17814,62014,19513,69213,24112,84612,47111,89811,63111,12210,7869,6399,5259,8349,0059,19112,84511,39010,2389,6078,1237,9507,6347,7615,5005,3117,8007,5204,7726,345445,6953905000000000001700
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,695
0
6,345
4,772
3,875
4,035
43
58
2,145
2,307
2,305
2,159
1,502
3,637
4,506
5,643
962
608
1,271
525
9,639
10,786
11,122
11,631
578
12,471
12,846
13,241
13,692
14,195
14,620
15,178
100
55
71
799
2,548
4,011
1,930
1,183
831
165
285
273
378
251
406
4062513782732851658311,1831,9304,0112,548799715510015,17814,62014,19513,69213,24112,84612,47157811,63111,12210,7869,6395251,2716089625,6434,5063,6371,5022,1592,3052,3072,14558434,0353,8754,7726,34505,69500000000000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,129
0
4,384
3,186
3,659
3,659
0
0
0
0
0
0
1,200
1,564
2,109
2,888
8,230
2,109
600
0
9,000
9,700
10,700
11,200
0
0
0
0
0
11,922
12,491
12,768
0
0
0
0
784
0
0
0
0
0
0
0
0
0
0
0000000000784000012,76812,49111,9220000011,20010,7009,7009,00006002,1098,2302,8882,1091,5641,2000000003,6593,6593,1864,38404,12900000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,200
1,564
8,993
10,090
8,230
8,396
600
0
9,000
9,700
10,700
11,200
0
11,448
11,525
11,600
11,723
11,922
12,491
12,768
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000012,76812,49111,92211,72311,60011,52511,448011,20010,7009,7009,00006008,3968,23010,0908,9931,5641,20000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
120
200
32
56
187
283
273
336
227
73
114
225
217
262
260
65
125
518
178
138
43
213
249
400
465
503
84
70
100
55
71
799
888
2,279
1,689
1,103
361
146
232
190
373
248
404
4042483731902321463611,1031,6892,279888799715510070845034654002492134313817851812565260262217225114732273362732831875632200120000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,567
0
1,961
1,586
96
175
11
2
1,958
2,024
2,032
1,823
75
1,823
1,823
1,823
47
346
411
459
512
568
243
294
534
94
94
0
0
1,770
2,045
2,339
0
55
-2
0
1,659
1,732
241
81
471
18
8
83
5
3
406
4063583818471812411,7321,6590-25502,3392,0451,770009494534294243568512459411346471,8231,8231,823751,8232,0322,0241,958211175961,5861,96101,56700000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,645
3,765
5,268
5,442
5,083
5,327
5,646
5,964
6,282
6,601
6,884
7,202
0
8,396
8,563
9,000
0
0
0
0
11,320
0
0
0
0
2,273
2,129
2,410
0
0
71
799
888
0
0
888
0
0
0
0
0
0
0
00000008880088879971002,4102,1292,273000011,32000009,0008,5638,39607,2026,8846,6016,2825,9645,6465,3275,0835,4425,2683,7653,645000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,230
8,396
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000008,3968,230000000000000000000000000000000000
> Total Stockholder Equity
0
0
-16
0
0
0
0
0
0
0
0
0
0
0
-36
-4,676
-39
-5,608
-5,608
-6,219
-4,352
-3,699
-4,584
-898
-2,199
-5,681
-3,012
-5,316
-7,050
-8,364
-8,270
-10,250
-10,904
-8,396
-8,534
-9,456
-7,174
-8,598
-9,972
-10,855
-11,382
-11,868
-12,465
-12,845
-13,239
-13,692
-14,124
-14,616
-15,125
6,575
6,039
5,588
4,402
5,947
2,772
5,693
3,793
2,906
3,675
2,909
3,792
3,484
2,911
6,596
6,5962,9113,4843,7922,9093,6752,9063,7935,6932,7725,9474,4025,5886,0396,575-15,125-14,616-14,124-13,692-13,239-12,845-12,465-11,868-11,382-10,855-9,972-8,598-7,174-9,456-8,534-8,396-10,904-10,250-8,270-8,364-7,050-5,316-3,012-5,681-2,199-898-4,584-3,699-4,352-6,219-5,608-5,608-39-4,676-3600000000000-1600
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
5
0
5
5
5
11
0
11
18
24
24
29
31
32
38
39
39
39
39
39
39
43
44
4
8
26
28
30
31
31
31
31
31
31
31
31
12
10
10
10
10
15
17
3
3
1
1
1
2
3
3
2
233211133171510101010123131313131313131302826844443393939393939383231292424181101155505000000000000
   Retained Earnings Total Equity0000000000000000-69,789-69,2970000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,676
0
0
-5,608
0
0
0
0
0
0
-4
0
0
0
1,823
0
0
0
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000002200001,823000-4000000-5,60800-4,676000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55,142
55,142
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000055,14255,1420000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
25
44
45
46
48
48
50
52
52
55
52
59
20
20
20
1,994
69
2,135
6,608
8,315
9,072
13,643
15,704
20,206
29,842
32,338
34,976
43,731
41,709
38,865
40,738
1,823
52,061
52,443
54,962
54,991
55,022
55,062
55,096
55,142
0
0
0
0
55,142
55,142
55,160
77,041
77,194
77,212
77,245
77,892
78,426
83,129
83,149
83,815
85,449
85,466
87,290
88,502
88,946
93,373
93,37388,94688,50287,29085,46685,44983,81583,14983,12978,42677,89277,24577,21277,19477,04155,16055,14255,142000055,14255,09655,06255,02254,99154,96252,44352,0611,82340,73838,86541,70943,73134,97632,33829,84220,20615,70413,6439,0728,3156,6082,135691,99420202059525552525048484645442500



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-4,219
Operating Income-4,219-4,219
 
Operating Expense (+$)
Research Development2,130
Selling General Administrative2,089
Selling And Marketing Expenses0
Operating Expense4,2194,219
 
Net Interest Income (+$)
Interest Income56
Interest Expense-0
Other Finance Cost-0
Net Interest Income56
 
Pretax Income (+$)
Operating Income-4,219
Net Interest Income56
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,112-4,326
EBIT - interestExpense = -8,331
-11,437
-4,112
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-8,331-4,112
Earnings Before Interest and Taxes (EBITDA)-4,112
 
After tax Income (+$)
Income Before Tax-4,112
Tax Provision-0
Net Income From Continuing Ops-4,112-4,112
Net Income-4,112
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,219
Total Other Income/Expenses Net107-56
 

Technical Analysis of Bone Biologics Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bone Biologics Corp. The general trend of Bone Biologics Corp is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bone Biologics Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Bone Biologics Corp Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bone Biologics Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.84 < 2.89 < 3.155.

The bearish price targets are: 2.33 > 1.95.

Know someone who trades $BBLG? Share this with them.πŸ‘‡

Bone Biologics Corp Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bone Biologics Corp. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bone Biologics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bone Biologics Corp.

Bone Biologics Corp Daily Moving Average Convergence/Divergence (MACD) ChartBone Biologics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bone Biologics Corp. The current adx is .

Bone Biologics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bone Biologics Corp.

Bone Biologics Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bone Biologics Corp.

Bone Biologics Corp Daily Relative Strength Index (RSI) ChartBone Biologics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bone Biologics Corp.

Bone Biologics Corp Daily Stochastic Oscillator ChartBone Biologics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bone Biologics Corp.

Bone Biologics Corp Daily Commodity Channel Index (CCI) ChartBone Biologics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bone Biologics Corp.

Bone Biologics Corp Daily Chande Momentum Oscillator (CMO) ChartBone Biologics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bone Biologics Corp.

Bone Biologics Corp Daily Williams %R ChartBone Biologics Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Bone Biologics Corp.

Bone Biologics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bone Biologics Corp.

Bone Biologics Corp Daily Average True Range (ATR) ChartBone Biologics Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bone Biologics Corp.

Bone Biologics Corp Daily On-Balance Volume (OBV) ChartBone Biologics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bone Biologics Corp.

Bone Biologics Corp Daily Money Flow Index (MFI) ChartBone Biologics Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bone Biologics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-09-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Bone Biologics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bone Biologics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.450
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bone Biologics Corp with someone you think should read this too:
  • Are you bullish or bearish on Bone Biologics Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bone Biologics Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bone Biologics Corp

I send you an email if I find something interesting about Bone Biologics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Bone Biologics Corp.

Receive notifications about Bone Biologics Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.